U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6004596

Sealed Crustless Sandwich

A sealed crustless sandwich for providing a convenient sandwich without an outer crust which can be stored for long periods of time without a central filling from leaking outwardly.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 540/451 - Chalcogen double bonded directly to a ring carbon of the hetero ring which is adjacent to the ring nitrogen (e.g., laurolactam, etc.)


Subclass of Class 540 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein chalcogen (i.e., oxygen, sulfur, selenium
No. of patents: 155
Last issue date: 10/05/2010


1        
NumberTitleIssue Date
7807826Purification of a crude lactam mixture by means of melt crystallization
The present invention provides a method for purifying laurolactam from a crude lactam mixture. In the method of the present invention, laurolactam is selectively crystallized by melt crystallization with controlled cooling of the crude lactam mixture. ...
10/05/2010
7579462Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
Efficient chemical processes for preparing high yields, purities, and different polymorphic forms of 17-allyl amino geldanamycin (17-AAG) and other ansamycins are described and claimed. ...
08/25/2009
7402675Process for the synthesis of amine ethers from secondary amino oxides
An amine ether of formula A wherein a is 1 or 2; and when a is 1, E is E′; when a is 2, E is L; E′ is C1-C36 alkyl; C3-C18 alkenyl; C2
07/22/2008
7323563Hydroxamic acid derivatives as antibacterials
A method for the treatment of bacterial infections in humans and non-human mammals, which comprises inhibiting bacterial growth by administering to a subject an antibacterially effective dose of a compound of formula (I) or a pharmaceutically or veterinarily accepta...
01/29/2008
7320974Cytoskeletal active compounds, compositions and use
The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable...
01/22/2008
7244594Microbial transformation method for the preparation of an epothilone
A microbial method for the preparation of an epothilone containing a terminal hydroxyalkyl group, comprising contacting at least one epothilone having a terminal alkyl group with an enzyme or microorganism capable of catalyzing the selective hydroxylation of said al...
07/17/2007
7192940Ether compounds
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a compo...
03/20/2007
7153978Method for purifying N-methyl-2-pyrrolidone
A method for purifying N-methyl-2-pyrrolidone is disclosed. The method comprises treating N-methyl-2-pyrrolidone with an alumina that desorbs less than 100 μmol/g of isobutylene between 225° C. and 400° C. in a standard tert-butyl alcohol dehydration test. The me...
12/26/2006
71258936-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
This invention describes the new 6-alkenyl- and 6-alkinyl-epothilone derivatives of general formula I in which R1a, R1b, R2a, R3a, R3b, R4, R...
10/24/2006
7122677NK1 antagonists
A NK1 antagonist having the formula (I), wherein Ar1 and Ar2 are optionally substituted phenyl or heteroaryl, X1 is an ether, thio or imino linkage, R4 and R5...
10/17/2006
7067544Epothilones C, D, E and F, preparation and compositions
The present invention relates to epothilones C, D, E and F, their preparation and their use for the production of therapeutic compositions and compositions for plant protection. ...
06/27/2006
7026310Heteroaryl derivatives and their use as medicaments
The invention relates to novel quinoline derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for treating tumors. ...
04/11/2006
7022844Amide-based compounds, production, recovery, purification and uses thereof
Methods are disclosed of producing and purifying at least one amide. In accordance with one of the methods disclosed herein, the at least one amide is produced by providing an organic liquid comprising at least one oxime, providing at least one catalyst, adding the ...
04/04/2006
6984734Cyclo[n]pyrroles and methods thereto
The present invention provides an oxidative coupling procedure that allows efficient synthesis of novel cyclo[n]pyrrole macrocycles. Therefore, the present invention provides cyclo[n]pyrroles where n is 6, 7, 8, 9, 10, 11, or 12, and derivatives, multimers, isomers,...
01/10/2006
6962992Crown ether derivatives
The invention describes crown ether chelators, including crown ethers having the formula and aza-substituted and thia-substituted analogs thereof. These crown ethers are substituted by a dye moiety, a chemically reacti...
11/08/2005
6936447Autoinducer molecule
Autoinducer molecules, e.g., N-(3-oxododecanoyl)homoserine lactone, for Pseudomonas aeruginosa are described. The molecules regulate gene expression in the bacterium. Therapeutic compositions and therapeutic methods involving analogs and/or inhibitors of the ...
08/30/2005
6906188Method for synthesizing epothilones and epothilone analogs
A method for making epothilones and epothilone analogs is described, as are novel compounds made by the method. Exemplary novel compounds include those according to the formula: With respect the formula, G is selected ...
06/14/2005
6900328Process for the synthesis of amine ethers from secondary amino oxides
An amine ether of formula (A) wherein a is 1 or 2; and when a is 1, E is E′; when a is 2, E is L; E′ is C1-C36 alkyl; C3-C18 alkenyl; C2-C18 alkinyl; C5-C18 cycloalkyl; C
05/31/2005
6890921Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
This invention relates to a series of arylsubstituted piperazines, of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibi...
05/10/2005
6852713Lactam derivatives and methods of their use
Lactam derivatives of the general formula are disclosed. Pharmaceutical compositions containing the compounds and methods for their use are also disclosed. ...
02/08/2005
6790953Ether compounds
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a compo...
09/14/2004
6747021Cryptophycin compound
The present invention provides antitumor methods, formulations, and compounds comprising a cryptophycin. ...
06/08/2004
6525197Methods for preparing macrocyclic products by ring-closing diyne metathessis
The present invention relates to methods for preparing macrocyclic products having 9 or more ring atoms by ring-closing diyne metathesis of suitable diyne substrates. The diyne substrates can be converted into cycloalkynes or into cycloalkadiynes by cyclo...
02/25/2003
6489314Epothilone derivatives and methods for making and using the same
The present invention relates to 16-membered macrocyclic compounds. In one aspect of the present invention, compounds of the formula ##STR1## are provided wherein: R1, R2, R3, and R5 are each independently hydrogen, ...
12/03/2002
6482944Processes for preparing tertiary aminoalkylorganometallic compounds
Processes for the preparation of haloalkylamines and tertiary aminoalkylorganometallic compounds are disclosed. The haloalkylamines can be prepared by direct reaction of an amine with an ଱, ω-dihaloalkane or an ଱, ω-dihaloalkene. Tertiary ...
11/19/2002
6468406Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
The invention is directed to an anion-complexing compound with the formula I ##STR1## wherein R1 is a six-membered ring, Y' is --NHC(X)NH--, and Y" is selected from the group consisting of --NHC(X')--, --C(X')NH--, and --NHC(X') NH--; and wherein X a...
10/22/2002
6384035Heterocycles useful in the treatment of benign prostatic hyperplasia
This invention relates a to a series of heterocyclic substituted piperazines of Formula I ##STR1## pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to ...
05/07/2002
6362333Method for simultaneously producing a cyclic lactam and a cyclic amine
A cyclic lactam and a cyclic amine are coproduced by coreacting an aliphatic alpha, omega-diamine and an aliphatic alpha, omega-aminonitrile with water in the gas phase in the presence of a heterogeneous catalyst....
03/26/2002
6362332Coproduction of a cyclic lactam and a cyclic amine
A cyclic lactam and a cyclic amine are coproduced by reacting an aliphatic alpha, omega-diamine with water in the gas phase in the presence of a heterogeneous catalyst....
03/26/2002
6313109Prenyl transferase inhibitors
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by the four following formulas ##STR1## Each of the R groups is defined in the disclosure....
11/06/2001
6281352Macrocyclic compounds as metalloprotease inhibitors
This invention relates to macrocyclic molecules which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). In particular, the compounds are inhibitors of metalloproteinases involved in tissue degradation an...
08/28/2001
6207824Purification of N-substituted lactams
A process for reducing the amine content of amine-contaminated N-substituted lactams comprises treating the contaminated N-substituted lactams with an acid macroporous cation exchanger....
03/27/2001
6180113Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes are useful in tumor therapy and interventional radiology....
01/30/2001
6174879Aminocyclohexylesters and uses thereof
Aminocyclohexylester compounds, including thioesters, are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and com...
01/16/2001
6143739Basic proline-amide derivatives of GE 2270 and GE 2270-like antibiotics
The present invention refers to basic amides derivatives of GE 2270 and GE 2270-like antibiotics of general formula (1), wherein the group GE represents the antibiotic core molecule. The amide derivatives of antibiotic GE 2270 of formula (I) are antimicro...
11/07/2000
6100394Long-lived homogenous oxidation catalysts
A robust chelate complex is provided having the formula: ##STR1## wherein: M is a metal, preferably a transition metal; Z is an anionic donor atom, three of which are nitrogen, and the other is oxygen; L1 is a labile ligand; Ch1...
08/08/2000
6100396Method for purifying lactams
A method for purifying lactams by liquid-liquid extraction and/or processing with an ion exchange resin is disclosed. The method is useful for purifying lactams produced by the cyclising vapour-phase hydrolysis of an aliphatic aminonitrile, and comprises ...
08/08/2000
6080771DC107 derivatives
DC107 derivatives represented by formula (I) or pharmaceutically acceptable salts thereof which have antimicrobial activity and antitumor activity are provided: ##STR1## wherein R1 represents CO(CR4A R4B)n1...
06/27/2000
6071915Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
This invention relates to a series of arylsubstituted piperazines, of Formula I ##STR1## pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the &...
06/06/2000
6054579Synthesis of substituted lactams
The invention relates to an efficient and facile method for the preparation of substituted lactams, as described herein. The method comprises reacting a difunctional component containing an activated carbon, an amine capable of forming an imine with the a...
04/25/2000
1        
 
Sign InRegister
Username  
Password   
forgot password?